Mark Froimson

CIK 1709050 · last filed 2026-03-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$462.9K

Companies

1

Total Filings

16

Lifetime Open-Market Net

-$103.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCRX Director 20,136 $22.99 $462.9K -$103.4K 16 2026-03-19

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-06-11 PCRX Grant (A) +1,260 $0 EDGAR
2019-12-19 PCRX Gift (G) −300 $0 EDGAR
2019-06-06 PCRX Grant (A) +4,134 $0 EDGAR
2018-06-15 PCRX Grant (A) +782 $0 EDGAR
2017-08-16 PCRX Buy (P) +100 $3.7K EDGAR
2017-06-16 PCRX Grant (A) $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.